MedPath
HSA Approval

LATACOM EYE DROPS

SIN16927P

LATACOM EYE DROPS

LATACOM EYE DROPS

January 12, 2024

DUOPHARMA (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantDUOPHARMA (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SOLUTION, STERILE

OPHTHALMIC

Medical Information

S01ED51

timolol, combinations

Manufacturer Information

DUOPHARMA (SINGAPORE) PTE. LTD.

Duopharma (M) Sdn Bhd

Active Ingredients

Latanoprost

0.05mg/mL

Latanoprost

Timolol Maleate EQV Timolol

5 mg/mL

Timolol

Documents

Package Inserts

LATACOM EYE DROPS PI.pdf

Approved: January 12, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LATACOM EYE DROPS - HSA Approval | MedPath